These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 10532519)
21. Acute hemodynamic effects of inhaled nitroglycerine, intravenous nitroglycerine, and their combination with intravenous dobutamine in patients with secondary pulmonary hypertension. Mandal B; Kapoor PM; Chowdhury U; Kiran U; Choudhury M Ann Card Anaesth; 2010; 13(2):138-44. PubMed ID: 20442544 [TBL] [Abstract][Full Text] [Related]
22. Targeting of dobutamine to ischemic myocardium without systemic effects by selective suction and pressure-regulated retroinfusion. von Degenfeld G; Giehrl W; Boekstegers P Cardiovasc Res; 1997 Aug; 35(2):233-40. PubMed ID: 9349386 [TBL] [Abstract][Full Text] [Related]
23. [Vasodilators, oral nitrate derivatives and treatment of heart failure]. Chiche P; Baligadoo S Coeur Med Interne; 1976; 15(2):139-46. PubMed ID: 825345 [No Abstract] [Full Text] [Related]
24. [Hemodynamic changes in patients with myocardial infarct complicated by acute left ventricular failure during combined nitroglycerin and dobutamine therapy]. Ol'binskaia LI; Poptsov VN; Gofman AM Kardiologiia; 1991 Apr; 31(4):49-51. PubMed ID: 1906121 [TBL] [Abstract][Full Text] [Related]
25. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact. Yamani MH; Haji SA; Starling RC; Kelly L; Albert N; Knack DL; Young JB Am Heart J; 2001 Dec; 142(6):998-1002. PubMed ID: 11717603 [TBL] [Abstract][Full Text] [Related]
26. [Comparative evaluation of the effectiveness of various peripheral vasodilators in the treatment of cardiac insufficiency]. Mukharliamov NM; Mareev VIu; Novikov SV; Evdokimova NKh; Ageev FT Ter Arkh; 1985; 57(5):89-94. PubMed ID: 3927501 [TBL] [Abstract][Full Text] [Related]
27. Combination vasodilator therapy for severe chronic congestive heart failure. Chatterjee K; Drew D; Parmley WW; Klausner SC; Polansky J; Zacherle B Ann Intern Med; 1976 Oct; 85(4):467-70. PubMed ID: 823852 [TBL] [Abstract][Full Text] [Related]
28. [The novelty in the treatment of heart failure]. Reingardiene D Medicina (Kaunas); 2005; 41(7):625-31. PubMed ID: 16062032 [TBL] [Abstract][Full Text] [Related]
29. [The effect of levosimendan and dobutamine treatment on QT dispersion in patients with decompensated heart failure: a prospective study]. Paksoy F; Ulaş T; Tursun I; Dal MS; Oztekin E; Borlu F Anadolu Kardiyol Derg; 2012 Feb; 12(1):16-22. PubMed ID: 22214738 [TBL] [Abstract][Full Text] [Related]
30. Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy. Sindone AP; Keogh AM; Macdonald PS; McCosker CJ; Kaan AF Am Heart J; 1997 Nov; 134(5 Pt 1):889-900. PubMed ID: 9398101 [TBL] [Abstract][Full Text] [Related]
31. Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension. Gavazzi A; Ghio S; Scelsi L; Campana C; Klersy C; Serio A; Raineri C; Tavazzi L Am Heart J; 2003 Feb; 145(2):310-6. PubMed ID: 12595849 [TBL] [Abstract][Full Text] [Related]